Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5TUL

Crystal structure of tetracycline destructase Tet(55)

Summary for 5TUL
Entry DOI10.2210/pdb5tul/pdb
Related5TUE 5TUF 5TUI 5TUK 5TUM
DescriptorTetracycline destructase Tet(55), PHOSPHATE ION (3 entities in total)
Functional Keywordsfad-binding, tetracycline-inactivating, oxidoreductase activity, oxidoreductase
Biological sourceuncultured bacterium
Total number of polymer chains1
Total formula weight45429.15
Authors
Park, J.,Tolia, N.H. (deposition date: 2016-11-06, release date: 2017-05-10, Last modification date: 2024-03-06)
Primary citationPark, J.,Gasparrini, A.J.,Reck, M.R.,Symister, C.T.,Elliott, J.L.,Vogel, J.P.,Wencewicz, T.A.,Dantas, G.,Tolia, N.H.
Plasticity, dynamics, and inhibition of emerging tetracycline resistance enzymes.
Nat. Chem. Biol., 13:730-736, 2017
Cited by
PubMed Abstract: Although tetracyclines are an important class of antibiotics for use in agriculture and the clinic, their efficacy is threatened by increasing resistance. Resistance to tetracyclines can occur through efflux, ribosomal protection, or enzymatic inactivation. Surprisingly, tetracycline enzymatic inactivation has remained largely unexplored, despite providing the distinct advantage of antibiotic clearance. The tetracycline destructases are a recently discovered family of tetracycline-inactivating flavoenzymes from pathogens and soil metagenomes that have a high potential for broad dissemination. Here, we show that tetracycline destructases accommodate tetracycline-class antibiotics in diverse and novel orientations for catalysis, and antibiotic binding drives unprecedented structural dynamics facilitating tetracycline inactivation. We identify a key inhibitor binding mode that locks the flavin adenine dinucleotide cofactor in an inactive state, functionally rescuing tetracycline activity. Our results reveal the potential of a new tetracycline and tetracycline destructase inhibitor combination therapy strategy to overcome resistance by enzymatic inactivation and restore the use of an important class of antibiotics.
PubMed: 28481346
DOI: 10.1038/nchembio.2376
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2 Å)
Structure validation

227344

數據於2024-11-13公開中

PDB statisticsPDBj update infoContact PDBjnumon